These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2547138)

  • 1. Effect of orally administered oestrogens on gonadotrophin levels in post-menopausal women.
    Aedo AR; Le Donne M; Landgren BM; Diczfalusy E
    Maturitas; 1989 Jun; 11(2):147-57. PubMed ID: 2547138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of orally administered oestrogens on circulating oestrogen profiles in post-menopausal women.
    Aedo AR; Sundén M; Landgren BM; Diczfalusy E
    Maturitas; 1989 Jun; 11(2):159-68. PubMed ID: 2547139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and biotransformation of orally administered oestrone sulphate and oestradiol valerate in post-menopausal women.
    Aedo AR; Landgren BM; Diczfalusy E
    Maturitas; 1990 Nov; 12(4):333-43. PubMed ID: 2124648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of piperazine oestrone sulphate on serum oestrogen and gonadotrophin levels in post-menopausal women.
    Isaacs AJ; Havard CW
    Clin Endocrinol (Oxf); 1978 Oct; 9(4):297-302. PubMed ID: 719904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma levels of oestrone, oestradiol and gonadotrophins in postmenopausal women after oral and vaginal administration of conjugated equine oestrogens (Premarin).
    Englund DE; Johansson ED
    Br J Obstet Gynaecol; 1978 Dec; 85(12):957-64. PubMed ID: 216384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of different oral oestrogen formulations on insulin-like growth factor-I, growth hormone and growth hormone binding protein in post-menopausal women.
    Kelly JJ; Rajkovic IA; O'Sullivan AJ; Sernia C; Ho KK
    Clin Endocrinol (Oxf); 1993 Nov; 39(5):561-7. PubMed ID: 8252746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The absorption and metabolism of oral oestradiol, oestrone and oestriol.
    Townsend PT; Dyer GI; Young O; Whitehead MI; Collins WP
    Br J Obstet Gynaecol; 1981 Aug; 88(8):846-52. PubMed ID: 6789863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma oestrone, oestradiol and gonadotrophin concentrations in postmenopausal patients treated with oestradiol or with a combination of oestradiol and oestriol.
    Sipinen S
    Ann Clin Res; 1979 Oct; 11(5):172-8. PubMed ID: 121048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oestrogens, gonadotropins and prolactin after intra-vaginal administration of oestriol in post-menopausal women.
    Keller PJ; Riedmann R; Fischer M; Gerber C
    Maturitas; 1981 Mar; 3(1):47-53. PubMed ID: 6789033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioactive LH in women with polycystic ovaries and the effect of gonadotrophin suppression.
    Mavroudis K; Evans A; Mamtora H; Anderson DC; Robertson WR
    Clin Endocrinol (Oxf); 1988 Dec; 29(6):633-41. PubMed ID: 2978466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laboratory criteria for menopause in women using oral contraceptives.
    Creinin MD
    Fertil Steril; 1996 Jul; 66(1):101-4. PubMed ID: 8752618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of Premarin and norgestrel on plasma FSH, LH and androstenedione in post-menopausal women.
    Sexton L; Anderton KJ; Lenton EA; Brooke LM; Cooke ID
    Postgrad Med J; 1978; 54 Suppl 2():42-6. PubMed ID: 216981
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of oestrogen replacement therapy on blood coagulation factors in postmenopausal women.
    Varma TR
    Int J Gynaecol Obstet; 1983 Aug; 21(4):291-6. PubMed ID: 6141083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of deliberate omission of Trinordiol or Microgynon on the hypothalamo-pituitary-ovarian axis.
    Smith SK; Kirkman RJ; Arce BB; McNeilly AS; Loudon NB; Baird DT
    Contraception; 1986 Nov; 34(5):513-22. PubMed ID: 3102162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
    Brenner PF; Mishell DR; Stanczyk FZ; Goebelsmann U
    Am J Obstet Gynecol; 1977 Sep; 129(2):133-40. PubMed ID: 900174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of natural estrogen on the serum level of follicle-stimulating hormone (FSH), estradiol and estrone in post-menopausal women and its effect on endometrium.
    Varma TR; Everard D; Hole D
    Acta Obstet Gynecol Scand; 1985; 64(2):105-9. PubMed ID: 2984875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
    Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of various oestrogens on circulating androgens and cortisol during replacement therapy in post-menopausal women.
    Helgason S; Carlström K; Damber MG; Damber JE; Selstam G; von Schoultz B
    Maturitas; 1981 Dec; 3(3-4):301-8. PubMed ID: 6278266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrinological features and endometrial morphology in climacteric women receiving hormone replacement therapy.
    Grasso A; Baraghini F; Barbieri C; Dalla Vecchia E; Previdi AM; Di Renzo GC; Volpe A
    Maturitas; 1982 Apr; 4(1):19-26. PubMed ID: 6285153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The significance of oestriol in the management of the post-menopause.
    Tzingounis VA; Aksu MF; Greenblatt RB
    Acta Endocrinol Suppl (Copenh); 1980; 233():45-50. PubMed ID: 6773286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.